FDA clears J&J drug for autism symptoms
(Reuters)


Reuters - A schizophrenia drug from Johnson &
Johnson won U.S. approval as the first medicine to treat
symptoms of autism in children and adolescents, the Food and
Drug Administration said on Friday.